---
title: "SPAC Bleichroeder Acquisition III files for a $300 million IPO, targeting technology"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290252196.md"
description: "Bleichroeder Acquisition III, a SPAC led by Andrew Gundlach and Marcello Padula, filed for a $300 million IPO targeting technology firms in North America or Europe. The offering involves 30 million units at $10 each, listing on Nasdaq under BCCQU with Cohen & Company as bookrunner. Previous SPACs include deals with Pasqual and Merlin."
datetime: "2026-06-18T22:42:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290252196.md)
  - [en](https://longbridge.com/en/news/290252196.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290252196.md)
generator: "portal-rs"
---

# SPAC Bleichroeder Acquisition III files for a $300 million IPO, targeting technology

Bleichroeder Acquisition III, a blank check company led by investment veterans targeting technology in North America or Europe, filed on Thursday with the SEC to raise up to $300 million in an initial public offering.

The company plans to raise $300 million by offering 30 million units at $10. Each unit consists of one share of common stock, and one-fourth of one warrant to purchase a share, exercisable at $11.50.

Bleichroeder Acquisition III led by **Executive Chairman Andrew Gundlach**, the Co-CEO of Bleichroeder and Head of Goldiron. He is joined by **CEO Marcello Padula**, a former Investment Banking VP of BofA Securities and **CFO Robert Folino**, the COO of Bleichroder. The SPAC intends to target North American and European businesses that are being transformed with technology adoption.

Management's previous SPACs include **Bleichroeder Acquisition II** (BBCQ; +4% from $10 offer price), which went public in January 2026 and is pending a business combination with quantum computer developer Pasqual, and Bleichroeder Acquisition I, which went public in 2024 and completed its business combination with aerospace firm **Merlin** (MRLN; -3%) in March 2026.

The New York, NY-based company was founded in 2026. It plans to list on the Nasdaq under the symbol BCCQU. Bleichroeder Acquisition III filed confidentially on May 19, 2026. Cohen & Company Securities is the sole bookrunner on the deal.

### Related Stocks

- [COHN.US](https://longbridge.com/en/quote/COHN.US.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [BBCQ.US](https://longbridge.com/en/quote/BBCQ.US.md)
- [MRLN.US](https://longbridge.com/en/quote/MRLN.US.md)
- [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md)
- [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md)
- [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md)
- [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md)
- [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md)
- [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md)
- [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md)
- [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md)
- [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md)
- [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md)
- [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md)
- [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md)
- [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md)
- [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md)
- [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md)
- [8648.JP](https://longbridge.com/en/quote/8648.JP.md)

## Related News & Research

- [The SPAC IPO Buzz: Inflection Point Acquisition VIII Raises $250 Million](https://longbridge.com/en/news/297353628.md)
- [SPAC FutureCore Acquisition files for a $75 million IPO, targeting growth and defensible market positions](https://longbridge.com/en/news/298768686.md)
- [D. Boral Capital to Host Inaugural D. Boral Capital SPAC Summit](https://longbridge.com/en/news/298631280.md)
- [BREAKINGVIEWS-Wild SPAC deal-hounds howl at moonshots](https://longbridge.com/en/news/298738805.md)
- [NewHold Sets Prepaid Share Forward to Support de-SPAC, Up to 7M Shares at ~$10.65](https://longbridge.com/en/news/298720456.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**